Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis

• Published in: Catheterization and cardiovascular interventions 2016-05, Vol.87 (6), p.1080-1091
• Main Authors: Goel, Sachin S., Dilip Gajulapalli, Rama, Athappan, Ganesh, Philip, Femi, Gupta, Supriya, Murat Tuzcu, E., Ellis, Stephen G., Mishkel, Gregory, Kapadia, Samir R.
• Format: Article
• Language: English
• Subjects: balloon; Coronary Angiography; Coronary Restenosis - diagnosis; Coronary Restenosis - therapy; Disease Management; drug coated/eluting; drug eluting; Drug-Eluting Stents - adverse effects; Humans; Prosthesis Design; Prosthesis Failure; stent; stent restenosis
• ISSN: 1522-1946; 1522-726X
• DOI: 10.1002/ccd.26151

Background The optimal management for coronary drug eluting stent in‐stent restenosis (DES ISR) is unclear. We performed a meta‐analysis of observational and randomized studies to compare the outcomes of management of DES ISR using DES, drug eluting balloon (DEB), or balloon angioplasty (BA). Methods Eligible studies (25 single arm and 13 comparative, including 4 randomized studies with a total of 7,474 patients with DES ISR) were identified using MEDLINE search and proceedings of international meetings. Outcomes studied include major adverse cardiac events (MACE), target lesion revascularization (TLR), target vessel revascularization (TVR), myocardial infarction (MI), stent thrombosis (ST), and mortality. Follow‐up ranged from 0.5 to 3.5 years (mean 1.4 years). Results The rate of TLR was significantly lower in the DES (odds ratio [OR] 0.50, 95% confidence interval [CI] 0.36–0.69) and DEB (OR 0.31, 95% CI 0.18–0.55) groups compared to BA. Similarly, TVR rate was significantly lower in the DES (OR 0.55, 95% CI 0.39–0.77) and DEB (OR 0.32, 95% CI 0.18–0.58) groups compared to BA. All other outcomes were similar between the DES/BA and DEB/BA comparisons. TLR was significantly lower in the DES group compared to BA for vessels  2.75 mm. Conclusion Treatment of coronary DES ISR with DES or DEB is associated with a reduction in the risk of TLR and TVR compared to BA alone. The relative risk reduction for TLR with DES is similar to DEB. DEBs have a potential role in the treatment of DES ISR by avoiding placement of another layer of stent. © 2015 Wiley Periodicals, Inc.